|
Dr. Farrell Melnick has over 20 years of experience in assessment and control of environmental, health and safety issues. This includes particulate and microbial hazards associated with hospital operations and renovations. He currently directs the health services program at RJLG. He leads a team of multi-disciplinary experts focused on addressing environmental monitoring and compliance challenges for some of the largest hospitals in the country. Specific services include USP 797 compliance consulting and training, infection control (best practices), employee exposure assessment (industrial health survey), industrial forensics (source identification), insurance claim investigation (worker's compensation, etc.), and environmental monitoring program development (microbial, particulates, endotoxins, and sterility testing). Prior to RJLG, Dr. Melnick served as senior industrial hygienist and safety engineer for Turner Construction at its New York office. He was responsible for health and safety oversight at major hospital construction sites including Bellevue, Memorial Sloan Kettering, North Shore University, Winthrop University and NYU Downtown Hospitals. He delivered industrial hygiene and infection control seminars, performed site surveys and interfaced with hospital personnel. Included in this work were coordination efforts with the hospital facility and engineering departments regarding infection and contaminant control, and the impact of construction on patients and personnel. Dr. Melnick has extensive project management experience with environmental site investigations. He has performed these for property transactions, as well as U.S. EPA Superfund Sites. In addition, he directed a site development study on Long Island which included assessment of air quality, asbestos, hazardous materials and noise projections associated with the conversion of property use. Dr. Melnick is a member of American Industrial Hygiene Association and American Society of Health System Pharmacists. He was appointed to the "Committee on Hazardous Drugs", NIOSH (National Institute of Occupational Safety and Health) in June 2006. He has published in peer-reviewed literature. | 